KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Gross Margin (2016 - 2025)

Historic Gross Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 90.99%.

  • Biolife Solutions' Gross Margin rose 27100.0% to 90.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 89.91%, marking a year-over-year increase of 36700.0%. This contributed to the annual value of 88.32% for FY2024, which is 50700.0% up from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Gross Margin is 90.99%, which was up 27100.0% from 89.25% recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Gross Margin peaked at 99.64% during Q4 2023, and registered a low of 79.32% during Q3 2023.
  • Its 5-year average for Gross Margin is 88.15%, with a median of 87.97% in 2021.
  • Per our database at Business Quant, Biolife Solutions' Gross Margin surged by 91600bps in 2023 and then plummeted by -95200bps in 2024.
  • Biolife Solutions' Gross Margin (Quarter) stood at 87.19% in 2021, then grew by 4bps to 90.48% in 2022, then grew by 10bps to 99.64% in 2023, then decreased by -10bps to 90.12% in 2024, then increased by 1bps to 90.99% in 2025.
  • Its last three reported values are 90.99% in Q3 2025, 89.25% for Q2 2025, and 89.15% during Q1 2025.